Pere Puigserver

Title: Pere Puigserver: Innovator in Metabolic Research

Introduction

Pere Puigserver is a distinguished inventor based in Brookline, MA, known for his significant contributions to the field of metabolic research. With a total of seven patents to his name, he has made remarkable strides in understanding and treating metabolic conditions, particularly diabetes.

Latest Patents

Among his latest patents is the invention titled "Selective inhibition of gluconeogenic activity." This invention provides compounds, pharmaceutical compositions, and methods for treating and/or preventing metabolic conditions such as diabetes. Another notable patent is "PGC-1 isoforms and uses therefor," which offers isolated nucleic acid molecules that encode novel isoforms of PGC-1 family members. This invention also includes antisense nucleic acid molecules, recombinant expression vectors, host cells, and nonhuman transgenic animals related to PGC-1 genes. Additionally, it provides isolated PGC-1 proteins, fusion proteins, antigenic peptides, and anti-PGC-1 antibodies, along with diagnostic methods utilizing these compositions.

Career Highlights

Pere Puigserver has had a notable career, working with prestigious institutions such as Dana-Farber Cancer Institute Inc. and The Scripps Research Institute. His work has significantly advanced the understanding of metabolic processes and their implications for health.

Collaborations

Throughout his career, he has collaborated with esteemed colleagues, including Bruce M Spiegelman and Guillaume Adelmant. These collaborations have further enriched his research and contributions to the field.

Conclusion

Pere Puigserver's innovative work in metabolic research has led to important advancements in the treatment of conditions like diabetes. His patents reflect a deep commitment to improving health outcomes through scientific discovery.